25-hydroxyprotopanaxadiol has been researched along with Pancreatic Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rayburn, ER; Wang, H; Wang, W; Zhang, R; Zhao, Y | 1 |
| Hao, M; Wang, H; Wang, W; Zhang, R; Zhao, Y | 1 |
2 other study(ies) available for 25-hydroxyprotopanaxadiol and Pancreatic Neoplasms
| Article | Year |
|---|---|
Novel ginsenosides 25-OH-PPD and 25-OCH3-PPD as experimental therapy for pancreatic cancer: anticancer activity and mechanisms of action.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Ginsenosides; Humans; Mice; Pancreatic Neoplasms; Proto-Oncogene Proteins c-mdm2; Triterpenes; Xenograft Model Antitumor Assays | 2009 |
Pharmacokinetics and tissue distribution of 25-hydroxyprotopanaxadiol, an anti-cancer compound isolated from Panax ginseng, in athymic mice bearing xenografts of human pancreatic tumors.
Topics: Administration, Oral; Animals; Antineoplastic Agents, Phytogenic; Biological Availability; Chromatography, Liquid; Dose-Response Relationship, Drug; Fruit; Ginsenosides; Humans; Injections, Intravenous; Male; Mice; Mice, Nude; Panax; Pancreatic Neoplasms; Tandem Mass Spectrometry; Tissue Distribution; Xenograft Model Antitumor Assays | 2011 |